Related references
Note: Only part of the references are listed.Accuracy, Safety, and Reliability of Novel Phase I Trial Designs
Heng Zhou et al.
CLINICAL CANCER RESEARCH (2018)
Uniformly most powerful Bayesian interval design for phase I dose-finding trials
Ruitao Lin et al.
PHARMACEUTICAL STATISTICS (2018)
Nonparametric overdose control with late-onset toxicity in phase I clinical trials
Ruitao Lin et al.
BIOSTATISTICS (2017)
A phase I trial of the MEK inhibitor selumetinib (AZD6244) in pediatric patients with recurrent or refractory low-grade glioma: a Pediatric Brain Tumor Consortium (PBTC) study
Anuradha Banerjee et al.
NEURO-ONCOLOGY (2017)
Keyboard: A Novel Bayesian Toxicity Probability Interval Design for Phase I Clinical Trials
Fangrong Yan et al.
CLINICAL CANCER RESEARCH (2017)
Bayesian optimal interval designs for phase I clinical trials
Suyu Liu et al.
JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES C-APPLIED STATISTICS (2015)
UNIFORMLY MOST POWERFUL BAYESIAN TESTS
Valen E. Johnson
ANNALS OF STATISTICS (2013)
Fractional Dose-Finding Methods with Late-Onset Toxicity in Phase I Clinical Trials
Guosheng Yin et al.
JOURNAL OF BIOPHARMACEUTICAL STATISTICS (2013)
Continual Reassessment Method for Partial Ordering
Nolan A. Wages et al.
BIOMETRICS (2011)
Bayesian hybrid dose-finding design in phase I oncology clinical trials
Ying Yuan et al.
STATISTICS IN MEDICINE (2011)
Approximate Bayesian Computation in Evolution and Ecology
Mark A. Beaumont
ANNUAL REVIEW OF ECOLOGY, EVOLUTION, AND SYSTEMATICS, VOL 41 (2010)
A modified toxicity probability interval method for dose-finding trials
Yuan Ji et al.
CLINICAL TRIALS (2010)
Model calibration in the continual reassessment method
Shing M. Lee et al.
CLINICAL TRIALS (2009)
Bayesian Model Averaging Continual Reassessment Method in Phase I Clinical Trials
Guosheng Yin et al.
JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION (2009)
Testing treatment effects in unconfounded studies under model misspecification: Logistic regression, discretization, and their combination
M. Z. Cangul et al.
STATISTICS IN MEDICINE (2009)
Cumulative cohort design for dose-finding
Anastasia Ivanova et al.
JOURNAL OF STATISTICAL PLANNING AND INFERENCE (2007)
The continual reassessment method for multiple toxicity grades: A Bayesian quasi-likelihood approach
Z. Yuan et al.
BIOMETRICS (2007)
Design efficiency in dose finding studies
X Paoletti et al.
COMPUTATIONAL STATISTICS & DATA ANALYSIS (2004)
Continual reassessment method for ordered groups
J O'Quigley et al.
BIOMETRICS (2003)
The bivariate continual reassessment method: extending the CRM to phase I trials of two competing outcomes
TA Braun
CONTROLLED CLINICAL TRIALS (2002)
A curve-free method for Phase I clinical trials
M Gasparini et al.
BIOMETRICS (2000)
Share Paper
